Funded Startups in Santa Rosa
Santa Rosa’s most recent funding entries span from 2021-08-17 (Radiant, $6M, Seed) to 2026-05-01 (Eliaz Therapeutics, $640K).
Santa Rosa’s most recent funding entries span from 2021-08-17 (Radiant, $6M, Seed) to 2026-05-01 (Eliaz Therapeutics, $640K). The disclosed amounts show a sharp outlier: Homebound’s $300M (2025-12-15) dwarfs the rest, including the next-largest disclosed round, Arbital Health’s $31M (2025-07-29) and Lumo’s $7M (2024-05-14).
The list also clusters temporally: three of nine rounds are in December 2025 (Compassion Without Borders on 2025-12-17 for $10K; Homebound on 2025-12-15 for $300M), and another is in July 2025 (Arbital Health on 2025-07-29 for $31M). In terms of sector and stage mix, Health Care appears in 2 of 9 entries (Eliaz Therapeutics; Arbital Health) while 6 of 9 entries are labeled “Series Unknown,” with only one clearly marked Seed above $1M (Lumo’s $7M on 2024-05-14) and one clear Venture - Series Unknown (Union Credit on 2022-10-24 for $2M).
Most recent rounds
9 shownRelated listings
Frequently asked
What stands out in the disclosed amount range for Santa Rosa, and how does the leader compare to other rounds?
Homebound’s $300M on 2025-12-15 is the dominant outlier in this set, with Arbital Health’s $31M (2025-07-29) the next-largest disclosed amount and Lumo’s $7M (2024-05-14) among the higher remaining rounds. Most other disclosed rounds sit far below the $31M level (e.g., Eliaz Therapeutics $640K on 2026-05-01 and Homebound-adjacent December entries under $10K aside from Homebound).
Do these funded startups cluster around specific time windows?
Yes. December 2025 contains two entries tied to mid-month timing (Homebound on 2025-12-15 for $300M and Compassion Without Borders on 2025-12-17 for $10K). Beyond that, there’s a separate July 2025 data point via Arbital Health on 2025-07-29 for $31M, while earlier rounds step back to 2024-05 (Lumo and Canine Companions for Independence) and then to 2022-09/10 and 2021-08.
What stage labeling patterns appear, and is “Series Unknown” dominant?
“Series Unknown” appears in 6 of 9 entries: Eliaz Therapeutics (2026-05-01, $640K), Compassion Without Borders (2025-12-17, $10K), Homebound (2025-12-15, $300M), Canine Companions for Independence (2024-05-13, $30K), Radiant (2021-08-17, $6M), plus Union Credit’s “Venture - Series Unknown” (2022-10-24, $2M). The remaining labeled rounds are Arbital Health (Series B, $31M on 2025-07-29), Lumo (Seed, $7M on 2024-05-14), and Operant Networks (Seed, $4M on 2022-09-19).
Which sectors are most represented in this Santa Rosa snapshot?
Health Care is the only sector recurring across multiple entries, appearing twice: Eliaz Therapeutics ($640K on 2026-05-01) and Arbital Health ($31M on 2025-07-29). Every other sector shows up once in the nine rows, including Biotechnology (Eliaz Therapeutics), Design (Homebound), Agriculture and Farming (Lumo), and Energy (Operant Networks).
Are there unusually small or large rounds that might skew analysis of the category?
Yes on both ends. Homebound’s $300M (2025-12-15) is dramatically larger than the rest, while the smallest disclosed amount is Compassion Without Borders at $10K (2025-12-17). That contrast is especially notable since both entries fall within two days of each other in December 2025.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.